ITCI
Intra-Cellular Therapies, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q1 2025 | 17 | +2 | 13.58M | $1.79B | +3 | −1 |
| Q4 2024 | 15 | +1 | 12.62M | $1.05B | +1 | — |
| Q3 2024 | 13 | -1 | 9.99M | $731.14M | +1 | −2 |
| Q2 2024 | 14 | — | 9.81M | $671.63M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Norges Bank ✦ (pasivo) | 1.94M | — | $133.13M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 1.69M | — | $115.52M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 1.69M | — | $115.52M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.43M | — | $97.83M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.43M | — | $97.83M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.25M | — | $85.81M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.25M | — | $85.81M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.25M | — | $85.81M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.25M | — | $85.81M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.25M | — | $85.81M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.25M | — | $85.81M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 889.10K | — | $60.89M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 580.36K | — | $39.75M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 580.36K | — | $39.75M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 554.19K | — | $37.96M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 501.17K | — | $34.33M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 499.01K | — | $34.18M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 499.01K | — | $34.18M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 222.40K | — | $15.23M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 133.67K | — | $9.16M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 133.67K | — | $9.16M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 105.43K | — | $7.22M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 105.43K | — | $7.22M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 105.43K | — | $7.22M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Gotham Asset Management ✦ | 5.29K | — | $362,038 | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Arrowstreet Capital ✦ | 3.91K | — | $268,000 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 1 acciones, $2,540 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.